<p>(A) HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and stained for VE-cadherin (green) and GM130 (red) (scale bar 50 μm). Inset are magnified on the right side and the Golgi apparatus is outlined as for the intensity measurements. (B) PAI-039 treatment leads to the accumulation of VE-cadherin at the Golgi apparatus, (C) whereas the size of the Golgi apparatus is decreased (n = 3, mean + SEM, ** p < 0.001).</p
<p>(A) Treatment with PP1 analog inhibits KSHV entry and intracellular trafficking in a dose-depende...
<p>(A) Staining of Ecad-GFP expressing MDCK cells for mannose-6 phosphate receptor. Scale bars are 2...
International audienceThe steady-state localization of Golgi-resident glycosylation enzymes in the G...
<p>(A) HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and total cell ...
<p>(A) HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and stained for...
<p>HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and total cell lysa...
<p>A) Cells were untreated or treated with 1 µM of PLD1 inhibitor or PLD2 inhibitor for 30 min and t...
<p>(A) HUVEC were transduced with lentivirus to express VE-cadherin-GFP. HUVEC were treated with PAI...
<p>(<b>A</b>) IFA showing co-localization of RVFV Gn (Red) and a GFP-fused Golgi marker (Green) in a...
<p>(A) HMDM were treated with ±30 µM MiTMAB for 2 h and cellular ApoE glycoform distribution was det...
<p>Ecad-GFP cells were nucleofected with shRNAs to silence Scrb and/or Vps29. After 3 d cells were f...
<p>(A) HUVECs were treated with mult VN (10 µg/mL). Confocal microscopy showed continuous and organi...
<p>A) Cells were untreated or treated with 0.5% 1-ButOH or 5 µg/mL BFA for the indicated times and t...
<p>(A,B) Representative (n=10 samples) micrographs of primary human glioma stained for VE-cadherin (...
<div><p>Background</p><p>Plasminogen activator inhibitor-1 (PAI-1), a serine protease inhibitor, is ...
<p>(A) Treatment with PP1 analog inhibits KSHV entry and intracellular trafficking in a dose-depende...
<p>(A) Staining of Ecad-GFP expressing MDCK cells for mannose-6 phosphate receptor. Scale bars are 2...
International audienceThe steady-state localization of Golgi-resident glycosylation enzymes in the G...
<p>(A) HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and total cell ...
<p>(A) HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and stained for...
<p>HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and total cell lysa...
<p>A) Cells were untreated or treated with 1 µM of PLD1 inhibitor or PLD2 inhibitor for 30 min and t...
<p>(A) HUVEC were transduced with lentivirus to express VE-cadherin-GFP. HUVEC were treated with PAI...
<p>(<b>A</b>) IFA showing co-localization of RVFV Gn (Red) and a GFP-fused Golgi marker (Green) in a...
<p>(A) HMDM were treated with ±30 µM MiTMAB for 2 h and cellular ApoE glycoform distribution was det...
<p>Ecad-GFP cells were nucleofected with shRNAs to silence Scrb and/or Vps29. After 3 d cells were f...
<p>(A) HUVECs were treated with mult VN (10 µg/mL). Confocal microscopy showed continuous and organi...
<p>A) Cells were untreated or treated with 0.5% 1-ButOH or 5 µg/mL BFA for the indicated times and t...
<p>(A,B) Representative (n=10 samples) micrographs of primary human glioma stained for VE-cadherin (...
<div><p>Background</p><p>Plasminogen activator inhibitor-1 (PAI-1), a serine protease inhibitor, is ...
<p>(A) Treatment with PP1 analog inhibits KSHV entry and intracellular trafficking in a dose-depende...
<p>(A) Staining of Ecad-GFP expressing MDCK cells for mannose-6 phosphate receptor. Scale bars are 2...
International audienceThe steady-state localization of Golgi-resident glycosylation enzymes in the G...